Biologicals for rheumatoid arthritis

BMJ. 2011 Jul 28:343:d4027. doi: 10.1136/bmj.d4027.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / economics
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / economics
  • Arthritis, Rheumatoid / therapy*
  • Biological Products / economics
  • Biological Products / pharmacology
  • Biological Products / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Administration Routes
  • Drug Costs
  • Drug Monitoring
  • Female
  • Forecasting
  • Humans
  • Middle Aged
  • Quality-Adjusted Life Years
  • Randomized Controlled Trials as Topic
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antirheumatic Agents
  • Biological Products
  • Tumor Necrosis Factor-alpha